Reacta Healthcare names new chair of board

Lario Therapeutics awarded USD2.4m in grants for neuronal calcium channel research

EMA validates Enhertu application for post-neoadjuvant HER2-positive early breast cancer

Merck reports positive Phase 3 data for Enflonsia in high-risk children across two RSV seasons

IBA and Shreeji sign agreement to deploy four cyclotrons for PET radiopharmaceuticals in India

AVEO Oncology completes first interim analysis in global Phase 3 FIERCE-HN study

Cedar Health Research opens new embedded research site within Texas Native Health

Merck and Mayo Clinic launch AI-driven drug discovery collaboration

Palisade Bio makes Clinical Advisory Board appointment

Liminatus Pharma prices USD4.0m public offering

Sanofi and Teva report durable phase 2b maintenance efficacy for duvakitug in ulcerative colitis and Crohn's disease

First Ascent Biomedical opens Functional Precision Medicine cancer lab in Miami

Nucleome Therapeutics names new chief scientific officer

Eli Lilly and Company reports positive Phase 3 LIBRETTO-432 results for Retevmo in early-stage RET fusion-positive NSCLC

Beyfortus study shows sustained reduction in infant RSV hospitalisations across two seasons